Results 21 to 30 of about 474,365 (309)

Keratoconus progression associated with hormone replacement therapy

open access: yesAmerican Journal of Ophthalmology Case Reports, 2019
Purpose: To report a postmenopausal patient with keratoconus who experienced significant progression after using hormone replacement therapy. Observations: A 51-year-old woman with previously stable keratoconus presented with acute disease progression ...
Giulia Coco   +4 more
doaj   +1 more source

The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: modifications to the androgen receptor [PDF]

open access: yes, 2005
Prostate cancer is the second most common male malignancy in the western world an increasing incidence in an ageing population. Treatment of advanced prostate cancer relies on androgen deprivation.
Edwards, J., Bartlett, J.M.S.
core   +1 more source

Which patients with prostate cancer are actually candidates for hormone therapy?

open access: yesInternational Brazilian Journal of Urology, 2004
In this article, we will try to address the following aspects: which factors are responsible of the introduction of new candidates for hormone therapy in prostate cancer, who are actually candidates for hormone therapy, classifying them on the basis of ...
Alessandro Sciarra   +5 more
doaj   +1 more source

Bioidentical Hormone Therapy [PDF]

open access: yesMayo Clinic Proceedings, 2011
The change in hormonal milieu associated with perimenopause and menopause can lead to a variety of symptoms that can affect a woman's quality of life. Postmenopausal hormone therapy (HT) is an effective, well-tolerated treatment for these symptoms. However, combined HT consisting of conjugated equine estrogen and medroxyprogesterone acetate has been ...
Julia A, Files   +2 more
openaire   +2 more sources

Breast Cancer Series: Hormone Therapy

open access: yesEDIS, 2011
Women who are at high risk of getting breast cancer and women who have had breast cancer may be prescribed daily oral medications to block the estrogen receptor site or decrease the production of estrogen. This 2-page fact sheet describes various hormone
Karen C. Daily, Martha C. Monroe
doaj   +5 more sources

Promotional tone in reviews of menopausal hormone therapy after the Women's Health Initiative: an analysis of published articles.

open access: yesPLoS Medicine, 2011
BackgroundEven after the Women's Health Initiative (WHI) found that the risks of menopausal hormone therapy (hormone therapy) outweighed benefit for asymptomatic women, about half of gynecologists in the United States continued to believe that hormones ...
Adriane Fugh-Berman   +4 more
doaj   +1 more source

Hormone therapy, menopause, and endothelial function

open access: yes, 2023
Wenner, Megan M.Cardiovascular diseases (CVD) continue to be the leading cause of death in the United States. The prevalence of CVD is greater in men than women until menopause, where the rates in women then not only reach, but exceed those in men.
Schwab, Allyson
core   +1 more source

Growth Hormone Deficiency in the Transition Period

open access: yesEndocrinology Research and Practice, 2019
The importance of continuing growth hormone therapy in the transition and adulthood periods must be studied in adolescents with growth hormone deficiency with childhood onset.
Doğuş VURALLI
doaj   +1 more source

Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation [PDF]

open access: yes, 2010
Study found that treatment with recombinant human growth hormone gave significantly greater benefits in stature for children with growth hormone deficiency (GHD), Turner syndrome, Prader–Willi syndrome, chronic renal insufficency, short stature homeobox ...
Bird, A.   +29 more
core   +1 more source

Symptom reporting and quality of life in the Estonian Postmenopausal Hormone Therapy Trial

open access: yesBMC Women's Health, 2008
Background The aim of the study was to determine the effect of postmenopausal hormone therapy on women's symptom reporting and quality of life in a randomized trial.
Rahu Mati   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy